Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

This study has been completed.
Information provided by (Responsible Party):
LEO Pharma Identifier:
First received: May 24, 2010
Last updated: June 13, 2014
Last verified: June 2014